From contacts and sealing, to cable assembly requirements and miniaturization, here’s a step-by-step guide for engineers to help them ask the right questions as they determine connectors they will be need for their devices.
This technology is poised to deliver cost benefits and advance innovation in manufacturing, and companies will have to focus on replacing old protocols relying on extensive up-front testing and validation of traditional production tools, and understand steps needed to satisfy their quality requirements in the future, describes a new McKinsey report.
Uber has taken the struggling, often unloved taxi industry and reinvented it successfully based largely on one premise: Customer is king. In stark contrast, the healthcare industry clearly does not seem to share this mantra.
As medical device complexity grows, the product development process often needs to improve in order to maintain device quality and safety, foster innovation, and reduce costs. Yet teams looking to make improvements often encounter resistance from management. This Ask the Expert focuses on how you can overcome barriers to improving the medical device development process.
From increasing focus on reimbursement and economic value, to impact of UDI and the medical device user fees, three industry experts discuss current market and regulatory trends and challenges shaping the medical device industry, and offer some effective strategies for companies to follow to remain competitive.
Multi-material molding, a process whereby at least one melt processible material is bonded with at least one other material to produce a single, molded component, allows designers to optimize material properties and costs, eliminate assembly processes, and even invent ground-breaking products that could not be manufactured otherwise.
The HALO trial represents a new opportunity for surgeons seeking a valve replacement for pediatric patients with no alternative approved treatment options.
Researchers are studying a new biomaterial that helps healthy cells adhere to the implant, fend off bacterial cells and thus, reduce the likelihood of the implant being rejected by the body.
Forty-three percent of pharma and life sciences executives now support FDA evaluating drugs and devices based on both clinical and economic effectiveness.
Telling the parent their child has a temperature of 38.674 °C may be an impressive engineering feat, but the last two digits have no real value and any time spent in development getting there was misspent.
